Trials / Completed
CompletedNCT00550602
Tracheobronchomalacia: Treatment Outcomes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate respiratory symptoms and their impact in the quality of life and after treatment of the respiratory condition (tracheobronchomalacia - TBM).
Detailed description
TBM is an abnormal collapse of the tracheal and bronchial walls. It is characterized by flaccidity of the supporting tracheal and bronchial structures and a significant reduction of airway diameter on expiration seen in the trachea and/or in the mainstem bronchi. Currently there is no available data on the efficacy of central airway stabilization for treating TBM. Our study would provide this important information and would establish the effect of central airway stabilization on symptoms, functional status, quality of life, lung function and exercise capacity in patients with symptomatic and severe TBM.
Conditions
Timeline
- Start date
- 2002-01-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2007-10-30
- Last updated
- 2017-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00550602. Inclusion in this directory is not an endorsement.